NDC 81607-019 – Liraglutide

Liraglutide 6 mg/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC81607-019

Product details

Brand name
Liraglutide
Generic name
Liraglutide
Labeler
Orbicular Pharmaceutical Technologies Private Limited
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
ANDA · ANDA217234
Marketed since
February 26, 2026
Listing expires
December 31, 2027
Pharmacologic class
GLP-1 Receptor Agonist

Active ingredients

Uses, dosage, side effects and warnings for Liraglutide →

Package NDC codes (2)

Package NDCDescriptionSince
81607-019-013 SYRINGE, PLASTIC in 1 CARTON (81607-019-01) / 3 mL in 1 SYRINGE, PLASTIC (81607-019-03)Feb 26, 2026
81607-019-025 SYRINGE, PLASTIC in 1 CARTON (81607-019-02) / 3 mL in 1 SYRINGE, PLASTIC (81607-019-03)Feb 26, 2026

Other Liraglutide products